{"id":"W4392015401","doi":"10.1159/000537966","title":"Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study","year":2024,"lang":"en","type":"article","venue":"Liver Cancer","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"National Cancer Institute; BeiGene","keywords":"Sorafenib; Hepatocellular carcinoma; Medicine; Quality of life (healthcare); Internal medicine; Oncology; Carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003555431,0.0002883528,0.0009632194,0.0004064882,0.00003359043,0.00001026556,0.0000714333,0.0001145207,0.0007010656],"category_scores_gemma":[0.0000423355,0.0002215517,0.0002523132,0.0007613647,0.00005003106,0.00008180305,0.00002207997,0.0001601611,0.00001941259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001435398,"about_ca_system_score_gemma":0.0009592182,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0858881,"about_ca_topic_score_gemma":0.01024503,"domain_scores_codex":[0.9976357,0.0002509823,0.0009259386,0.0004427444,0.0004131933,0.0003315063],"domain_scores_gemma":[0.9989222,0.0003355535,0.0001673953,0.0003405458,0.00007607088,0.0001582524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005740613,0.003050892,0.9810784,0.0004892806,0.0004981208,0.0003973901,0.004711199,0.0002609194,0.0001222311,0.00006863594,0.0001040576,0.003478253],"study_design_scores_gemma":[0.02686087,0.01209174,0.9356171,0.0005515221,0.0002535985,0.000003750742,0.0004674291,0.02129673,0.002332692,0.0000388589,0.0002153717,0.0002703601],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9605668,0.03606784,0.000002957267,0.0006202271,0.000215801,0.002141004,0.000144127,0.00002994935,0.0002113514],"genre_scores_gemma":[0.9976474,0.001504713,0.00002004629,0.00001884473,0.00006471422,0.0003141083,0.0001261425,0.00003373148,0.0002702859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07564307,"threshold_uncertainty_score":0.920199,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1663480367441998,"score_gpt":0.3602734384689181,"score_spread":0.1939254017247184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}